Skip page header and navigation

Hill Dickinson’s Private Equity team advises NorthEdge on multi-million-pound investment into Antibody Analytics

Hill Dickinson’s Private Equity team advises NorthEdge on multi-million-pound investment into Antibody Analytics

Commercial law firm Hill Dickinson has advised private equity firm NorthEdge on its multi-million-pound investment into Antibody Analytics, a leading provider of immunology research services.

Antibody Analytics is a contract research organisation (CRO) that provides services in the field of pre-clinical drug discovery to an international client base of biopharmaceutical companies.

The strategic investment represents an exciting new chapter for the organisation, which will include significant job creation and expansion of its site, together with investment in high-tech equipment, to create world-class facility with additional capacity and research capabilities.

Founded in 2015, the ability to turbo-charge the growth of Antibody Analytics at this point will reinforce its position as a recognised global leader in pre-clinical immunology research services.

Hill Dickinson’s Private Equity team, led by partners David Mkhitarian and James Down, and senior associate Graeme Anderson, provided advice to NorthEdge, with support from Tasha Millar (corporate), Kathryn Wilson (employment), James Lonsdale (commercial), Patrick Reade (commercial), Jodie Wootton (commercial), Saba Mumraz (commercial), James Lock (commercial), Joyce Tai (commercial), David Baines (commercial), Eleanor Tunnicliffe (commercial), Paula Warnock (pensions), Frances Bailey (pensions) and Steven Betts (tax).

David Mkhitarian said: “We were delighted to have supported NorthEdge on another healthcare investment. Deals like this not only demonstrate the speed and incredible pace of innovation in life sciences but the willingness of investors to support businesses like Antibody Analytics to grow their market share on a world stage.”

James Down added “This is another fantastic deal for our Private Equity team. It was a pleasure to work with the team at NorthEdge and support them on their latest investment. The partnership with Antibody Analytics is a great fit and with NorthEdge’s backing, the business has the perfect platform to continue with its next stage of growth.”

Liam May, Director at NorthEdge, added: “We are committed to investing in people, technology and infrastructure to support businesses that improve global health outcomes.

“Antibody Analytics has a track record of developing strategically important services, alongside a pipeline of R&D projects that will further cement its reputation as a leader in its field. The value creation plan leverages the company’s culture of innovation and blends it with a continued focus on quality, client service and a market-leading employee value proposition to facilitate scale.”

Delivering a high-quality combination of technical expertise, commercial acumen and excellent client service, our clients value the quality of our people, our market knowledge and our commitment to achieving success for them. We always aim to exceed their expectations.

Our highly experienced and recognised corporate team operates from our offices in Liverpool, Manchester, London, Leeds, Hong Kong and Singapore. We offer our clients accessible corporate support from our experienced national and international network and specialise in advising a range of clients, from large listed companies and private equity funds to smaller start-up and owner-managed businesses and management teams on the full range of transactions – both domestic and cross-border. Our advice is distinctly commercial and focused on our clients’ commercial goals.

We work in small partner-led teams, providing our clients with easy access to our partners on transactions. We offer an innovative approach to managing client relationships and fee arrangements, which sets us apart from many of our competitors. We are able to offer our clients a timely, relevant and cost-effective service, that adds real value to the transaction process.